Catalyst Wire Dossier Catalyst Wire Dossier

VONJO

pacritinib · Sobi, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for VONJO, covering 2022-02-28 to 2026-03-18. Get the full timeline:

Most recent: FDA Approved: VONJO — Supplemental Application (Sobi, Inc.)

See pricing